INVITRO ACTIVITY OF FCE-22101, IMIPENEM, AND CEFTAZIDIME AGAINST OVER 6,000 BACTERIAL ISOLATES AND MIC QUALITY-CONTROL LIMITS OF FCE-22101

被引：3

作者：

BARRY, AL

ALDRIDGE, KE

ALLEN, SD

FUCHS, PC

GERLACH, EH

JONES, RN

PFALLER, MA

机构：

[1] ST VINCENT HOSP & MED CTR,PORTLAND,OR

[2] LOUISIANA STATE UNIV,BATON ROUGE,LA 70803

[3] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46204

[4] ST FRANCIS REG MED CTR,WICHITA,KS 67214

[5] UNIV IOWA,MED CTR,IOWA CITY,IA 52242

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1988年 / 7卷 / 06期

关键词：

D O I：

10.1007/BF01975053

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：794 / 798

页数：5

共 7 条

[1] QUALITY-CONTROL LIMITS FOR MICRODILUTION SUSCEPTIBILITY TESTS WITH AZTREONAM, IMIPENEM, CEFTRIAXONE, CEFTAZIDIME, CEFTIZOXIME, CEFUROXIME, AND CEFONICID [J].

BARRY, AL ;

GAVAN, TL ;

JONES, RN ;

AYERS, LW ;

FUCHS, PC ;

GERLACH, EH ;

THORNSBERRY, C .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 7 (01) :83-87

[2]

FRANCESCHI G, 1983, J ANTIBIOT, V36, P105

[3] THE INVITRO ACTIVITY OF A NOVEL PENEM FCE-22101 COMPARED TO OTHER BETA-LACTAM ANTIBIOTICS [J].

NEU, HC ;

CHIN, NX ;

LABTHAVIKUL, P .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (03) :305-313

[4] SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO FCE-22101 [J].

NORD, CE ;

LINDMARK, A ;

PERSON, I .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :831-833

[5]

VANDERAUWERA P, 1987, J ANTIMICROB CHEMOTH, V20, P179

[6] COMPARISON OF INVITRO ACTIVITY OF FCE 22101, A NEW PENEM, WITH THOSE OF OTHER BETA-LACTAM ANTIBIOTICS [J].

WISE, R ;

ANDREWS, JM ;

DANKS, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (06) :909-914

[7]

1985, STANDARD METHODS DIL

← 1 →